Digitisation | February 25, 2025
Amgen opens new technology and innovation site in Hyderabad
Amgen India investment totals $200 million through 2025
Amgen India investment totals $200 million through 2025
Ibuprofen and famotidine combination is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
During the quarter, US formulations revenue decreased by 2.3% YoY to Rs. 3,671 crore.
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
These results represent critical milestones for Philogen, as Fibromun has the potential to become second product to successfully complete multinational clinical trials with registration potential
Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
Subscribe To Our Newsletter & Stay Updated
